simulationName;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;R-square;pValue;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd
;5^{th}-Individual ID 66;5^{th}-Individual ID 66;5^{th}-Individual ID 66;5^{th}-Individual ID 66;5^{th}-Individual ID 66;;;95^{th}-Individual ID 14;95^{th}-Individual ID 14;95^{th}-Individual ID 14;95^{th}-Individual ID 14;95^{th}-Individual ID 14
;Lipophilicity;Specific intestinal permeability (transcellular);Raltegravir-UGT1A9-Kassahun 2007|In vitro Vmax for liver microsomes;Raltegravir-UGT1A1-Kassahun 2007|In vitro Vmax for liver microsomes;Dissolution shape;;;Lipophilicity;Specific intestinal permeability (transcellular);Raltegravir-UGT1A9-Kassahun 2007|In vitro Vmax for liver microsomes;Raltegravir-UGT1A1-Kassahun 2007|In vitro Vmax for liver microsomes;Dissolution shape
;-0.358368927992771;0.0798417274095072;-0.331394815288469;-0.409400033454385;0.885074744258986;;;-1.15882610141427;0.665980080047284;-0.753393232085798;-1.58307726800765;3.70779567888482
;-0.373447127812493;0.0780692688629479;-0.345772574539905;-0.43267337797213;0.85837688442171;;;-33.7000319831934;-31.8139897600204;-33.2751503914403;-34.1551989496418;-28.7511132831503
;-0.34329072817305;0.0816141859560664;-0.317017056037034;-0.386126688936639;0.911772604096262;;;31.3823797803648;33.1459499201149;31.7683639272688;30.9890444136265;36.16670464092
;0.999475905372861;0.999854041962201;0.999442752660742;0.999043675220689;0.999730551946737;;;0.00426299491547488;0.00141734695983076;0.0018084654713475;0.00791158361460531;0.0421932110885088
;5.0929770873514e-06;7.48427791730253e-07;5.58384671308345e-06;1.25551417760383e-05;1.8773124002484e-06;;;0.916927237508996;0.952076825134019;0.945870467915726;0.886898566352613;0.740315034646128
